D Anitha1, Kai Mei2, Michael Dieckmeyer2, Felix K Kopp2, Nico Sollmann3, Claus Zimmer3, Jan S Kirschke3, Peter B Noel2, Thomas Baum3, Karupppasamy Subburaj4. 1. Engineering Product Development (EPD) Pillar, Singapore University of Technology and Design (SUTD), 8 Somapah Road, 487372, Singapore, Singapore. 2. Department of Radiology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany. 3. Department of Neuroradiology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany. 4. Engineering Product Development (EPD) Pillar, Singapore University of Technology and Design (SUTD), 8 Somapah Road, 487372, Singapore, Singapore. subburaj@sutd.edu.sg.
Abstract
PURPOSE: The aim of this study was to compare vertebral failure loads, predicted from finite element (FE) analysis of patients with and without osteoporotic vertebral fractures (OVF) at virtually reduced dose levels, compared to standard-dose exposure from multidetector computed tomography (MDCT) imaging and evaluate whether ultra-low dose derived FE analysis can still differentiate patient groups. MATERIALS AND METHODS: An institutional review board (IRB) approval was obtained for this retrospective study. A total of 16 patients were evaluated at standard-dose MDCT; eight with and eight without OVF. Images were reconstructed at virtually reduced dose levels (i. e. half, quarter and tenth of the standard dose). Failure load was determined at L1-3 from FE analysis and compared between standard, half, quarter, and tenth doses and used to differentiate between fracture and control groups. RESULTS: Failure load derived at standard dose (3254 ± 909 N and 3794 ± 984 N) did not significantly differ from half (3390 ± 890 N and 3860 ± 1063 N) and quarter dose (3375 ± 915 N and 3925 ± 990 N) but was significantly higher for one tenth dose (4513 ± 1762 N and 4766 ± 1628 N) for fracture and control groups, respectively. Failure load differed significantly between the two groups at standard, half and quarter doses, but not at tenth dose. Receiver operating characteristic (ROC) curve analysis also demonstrated that standard, half, and quarter doses can significantly differentiate the fracture from the control group. CONCLUSION: The use of MDCT enables a dose reduction of at least 75% compared to standard-dose for an adequate prediction of vertebral failure load based on non-invasive FE analysis.
PURPOSE: The aim of this study was to compare vertebral failure loads, predicted from finite element (FE) analysis of patients with and without osteoporotic vertebral fractures (OVF) at virtually reduced dose levels, compared to standard-dose exposure from multidetector computed tomography (MDCT) imaging and evaluate whether ultra-low dose derived FE analysis can still differentiate patient groups. MATERIALS AND METHODS: An institutional review board (IRB) approval was obtained for this retrospective study. A total of 16 patients were evaluated at standard-dose MDCT; eight with and eight without OVF. Images were reconstructed at virtually reduced dose levels (i. e. half, quarter and tenth of the standard dose). Failure load was determined at L1-3 from FE analysis and compared between standard, half, quarter, and tenth doses and used to differentiate between fracture and control groups. RESULTS: Failure load derived at standard dose (3254 ± 909 N and 3794 ± 984 N) did not significantly differ from half (3390 ± 890 N and 3860 ± 1063 N) and quarter dose (3375 ± 915 N and 3925 ± 990 N) but was significantly higher for one tenth dose (4513 ± 1762 N and 4766 ± 1628 N) for fracture and control groups, respectively. Failure load differed significantly between the two groups at standard, half and quarter doses, but not at tenth dose. Receiver operating characteristic (ROC) curve analysis also demonstrated that standard, half, and quarter doses can significantly differentiate the fracture from the control group. CONCLUSION: The use of MDCT enables a dose reduction of at least 75% compared to standard-dose for an adequate prediction of vertebral failure load based on non-invasive FE analysis.
Authors: Jan S Bauer; Irina Sidorenko; Dirk Mueller; Thomas Baum; Ahi Sema Issever; Felix Eckstein; Ernst J Rummeny; Thomas M Link; Christoph W Raeth Journal: Eur J Radiol Date: 2013-11-08 Impact factor: 3.528
Authors: S C E Schuit; M van der Klift; A E A M Weel; C E D H de Laet; H Burger; E Seeman; A Hofman; A G Uitterlinden; J P T M van Leeuwen; H A P Pols Journal: Bone Date: 2004-01 Impact factor: 4.398
Authors: Hans Liebl; Eduardo Grande Garcia; Fabian Holzner; Peter B Noel; Rainer Burgkart; Ernst J Rummeny; Thomas Baum; Jan S Bauer Journal: PLoS One Date: 2015-02-27 Impact factor: 3.240
Authors: Kai Mei; Felix K Kopp; Rolf Bippus; Thomas Köhler; Benedikt J Schwaiger; Alexandra S Gersing; Andreas Fehringer; Andreas Sauter; Daniela Münzel; Franz Pfeiffer; Ernst J Rummeny; Jan S Kirschke; Peter B Noël; Thomas Baum Journal: Eur Radiol Date: 2017-06-21 Impact factor: 5.315
Authors: Nithin Manohar Rayudu; Michael Dieckmeyer; Maximilian T Löffler; Peter B Noël; Jan S Kirschke; Thomas Baum; Karupppasamy Subburaj Journal: Front Endocrinol (Lausanne) Date: 2021-01-19 Impact factor: 5.555
Authors: Long Yu Yeung; Nithin Manohar Rayudu; Maximilian Löffler; Anjany Sekuboyina; Egon Burian; Nico Sollmann; Michael Dieckmeyer; Tobias Greve; Jan S Kirschke; Karupppasamy Subburaj; Thomas Baum Journal: Diagnostics (Basel) Date: 2021-01-30
Authors: Tobias Greve; Nithin Manohar Rayudu; Michael Dieckmeyer; Christof Boehm; Stefan Ruschke; Egon Burian; Christopher Kloth; Jan S Kirschke; Dimitrios C Karampinos; Thomas Baum; Karupppasamy Subburaj; Nico Sollmann Journal: Front Endocrinol (Lausanne) Date: 2022-07-11 Impact factor: 6.055
Authors: Nico Sollmann; Nithin Manohar Rayudu; John Jie Sheng Lim; Michael Dieckmeyer; Egon Burian; Maximilian T Löffler; Jan S Kirschke; Thomas Baum; Karupppasamy Subburaj Journal: Quant Imaging Med Surg Date: 2021-07
Authors: Nithin Manohar Rayudu; Karupppasamy Subburaj; Kai Mei; Michael Dieckmeyer; Jan S Kirschke; Peter B Noël; Thomas Baum Journal: Front Endocrinol (Lausanne) Date: 2020-07-28 Impact factor: 5.555
Authors: Nico Sollmann; Nithin Manohar Rayudu; Long Yu Yeung; Anjany Sekuboyina; Egon Burian; Michael Dieckmeyer; Maximilian T Löffler; Benedikt J Schwaiger; Alexandra S Gersing; Jan S Kirschke; Thomas Baum; Karupppasamy Subburaj Journal: Diagnostics (Basel) Date: 2021-03-06